<DOC>
	<DOC>NCT01152814</DOC>
	<brief_summary>This study will evaluate the safety and immunogenicity of a sub-unit, adjuvanted influenza vaccine administered to elderly subjects</brief_summary>
	<brief_title>Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Key Males and females volunteers of 65 years of age or older Mentally competent Willing and able to give written informed consent prior to study entry. Able to comply with all the study requirements. In general good health Key Any serious chronic or acute disease History of any anaphylactic reaction and/or serious allergic reaction following a vaccination Known or suspected impairment/alteration of immune function Bleeding diathesis or conditions associated with prolonged bleeding time that in the investigator's opinion would interfere with the safety of the subject Within the past 6 months, they have had laboratory confirmed influenza disease or received influenza vaccine Fever (i.e., axillary temperature ≥38°C) within the last 3 days of intended study vaccination Individuals who received any other vaccines within 4 weeks prior to enrollment in this study or who are planning to receive any vaccine within 4 weeks from the study vaccines</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Seasonal influenza</keyword>
	<keyword>Vaccine</keyword>
</DOC>